{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:21:05Z","timestamp":1793121665686,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.mcpro.2026.101610","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:55:06Z","timestamp":1782284106000},"page":"101610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Extracellular Vesicles From Glioblastoma Cells Reflect 2D vs. 3D Culture Adaptation and Resistance to Temozolomide"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6940-401X","authenticated-orcid":false,"given":"Getulio Pereira de","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6280-4790","authenticated-orcid":false,"given":"Alan","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5995-5950","authenticated-orcid":false,"given":"Cintia C.","family":"Palu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Bogut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4163-3480","authenticated-orcid":false,"given":"Stephanie","family":"Chidester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Tigges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6444-6082","authenticated-orcid":false,"given":"Rafael A.","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionita C.","family":"Ghiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4691-8488","authenticated-orcid":false,"given":"Alexander R.","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcpro.2026.101610_bib1","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.mcpro.2026.101610_bib2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamaoncol.2018.1789","article-title":"Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014","volume":"4","author":"Ostrom","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.mcpro.2026.101610_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/8013575","article-title":"Diagnostic and therapeutic biomarkers in glioblastoma: current status and future perspectives","volume":"2017","author":"Szopa","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.mcpro.2026.101610_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood\u2013brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.mcpro.2026.101610_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12094-017-1763-6","article-title":"SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017)","volume":"20","author":"Mart\u00ednez-Garcia","year":"2018","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.mcpro.2026.101610_bib6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/mol.54.2.334","article-title":"Involvement of the mismatch repair system in temozolomide-induced apoptosis","volume":"54","author":"D\u2019Atri","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mcpro.2026.101610_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11060-019-03211-1","article-title":"Super-early initiation of temozolomide prolongs the survival of glioblastoma patients without gross-total resection: a retrospective cohort study","volume":"144","author":"Jiang","year":"2019","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.mcpro.2026.101610_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.bjc.6605712","article-title":"Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide","volume":"103","author":"van Nifterik","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mcpro.2026.101610_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41416-019-0603-6","article-title":"Circulating biomarkers in patients with glioblastoma","volume":"122","author":"M\u00fcller","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mcpro.2026.101610_bib10","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ncb1800","article-title":"Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers","volume":"10","author":"Skog","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.mcpro.2026.101610_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/cgt.2016.48","article-title":"Glioblastoma: exosome and microRNA as novel diagnosis biomarkers","volume":"23","author":"Saadatpour","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.mcpro.2026.101610_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell Vesicles"},{"key":"10.1016\/j.mcpro.2026.101610_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41556-018-0040-4","article-title":"Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.mcpro.2026.101610_bib14","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/s41556-021-00805-8","article-title":"Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets","volume":"23","author":"Zhang","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.mcpro.2026.101610_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911782","article-title":"Cancer three-dimensional spheroids mimic in vivo tumor features, displaying \u201cInner\u201d extracellular vesicles and vasculogenic mimicry","volume":"23","author":"Giusti","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcpro.2026.101610_bib16","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.3390\/ijms20204972","article-title":"Small extracellular vesicles released from ovarian cancer spheroids in response to cisplatin promote the pro-tumorigenic activity of mesenchymal stem cells","volume":"20","author":"Vera","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcpro.2026.101610_bib17","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.bbrc.2017.12.072","article-title":"A novel 3D heterotypic spheroid model for studying extracellular vesicle-mediated tumour and immune cell communication","volume":"495","author":"Sadovska","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mcpro.2026.101610_bib18","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.21873\/anticanres.12836","article-title":"Extracellular vesicles derived from hypoxic colorectal cancer cells confer metastatic phenotype to non-metastatic cancer cells","volume":"38","author":"ENDZELI\u0145\u0160","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mcpro.2026.101610_bib19","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1007\/s00018-019-03052-1","article-title":"Extracellular vesicle release from intestinal organoids is modulated by Apc mutation and other colorectal cancer progression factors","volume":"76","author":"Szvicsek","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.mcpro.2026.101610_bib20","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1038\/s41598-022-07451-6","article-title":"Proteomic analysis distinguishes extracellular vesicles produced by cancerous versus healthy pancreatic organoids","volume":"12","author":"Buenafe","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcpro.2026.101610_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj9793","article-title":"Intracellular proteomics and extracellular vesiculomics as a metric of disease recapitulation in 3D-bioprinted aortic valve arrays","volume":"10","author":"Clift","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mcpro.2026.101610_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11060-019-03262-4","article-title":"Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics","volume":"144","author":"Indira Chandran","year":"2019","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.mcpro.2026.101610_bib23","doi-asserted-by":"crossref","DOI":"10.5114\/aoms.2016.63743","article-title":"2D and 3D cell cultures \u2013 a comparison of different types of cancer cell cultures","author":"Kapa\u0142czy\u0144ska","year":"2016","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.mcpro.2026.101610_bib24","article-title":"Impact of atorvastatin loaded exosome as an anti-glioblastoma carrier to induce apoptosis of U87 cancer cells in 3D culture model","volume":"23","author":"Nooshabadi","year":"2020","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.mcpro.2026.101610_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/cancers13020307","article-title":"3D cell cultures as prospective models to Study extracellular vesicles in cancer","volume":"13","author":"Bordanaba-Florit","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mcpro.2026.101610_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.00033","article-title":"Is it time to start transitioning from 2D to 3D cell culture?","volume":"7","author":"Jensen","year":"2020","journal-title":"Front Mol. Biosci."},{"issue":"6","key":"10.1016\/j.mcpro.2026.101610_bib27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/cyto.a.23782","article-title":"FCM PASS software aids extracellular vesicle light scatter standardization","volume":"97","author":"Welsh","year":"2020","journal-title":"Cytometry A"},{"key":"10.1016\/j.mcpro.2026.101610_bib28","article-title":"MPAPASS software enables stitched multiplex, multidimensional EV repertoire analysis and a standard framework for reporting bead-based assays","volume":"2","author":"Welsh","year":"2022","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.mcpro.2026.101610_bib29","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1021\/acs.jproteome.0c00890","article-title":"Simple and efficient Microsolid-Phase extraction tip-based sample preparation workflow to enable sensitive proteomic profiling of limited samples (200 to 10,000 cells)","volume":"20","author":"Kostas","year":"2021","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mcpro.2026.101610_bib30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nprot.2017.147","article-title":"Proteome-wide identification of ubiquitin interactions using UbIA-MS","volume":"13","author":"Zhang","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mcpro.2026.101610_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12859-015-0611-3","article-title":"InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams","volume":"16","author":"Heberle","year":"2015","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.mcpro.2026.101610_bib32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/pharmaceutics15020663","article-title":"Production and utility of extracellular vesicles with 3D culture methods","volume":"15","author":"Casajuana Ester","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mcpro.2026.101610_bib33","series-title":"Possibilities and Limitations in Current Translational Stem Cell Research","article-title":"3D culturing of stem cells: an emerging technique for advancing fundamental research in regenerative medicin","author":"Rawat","year":"2023"},{"key":"10.1016\/j.mcpro.2026.101610_bib34","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3390\/pharmaceutics12121186","article-title":"Three-Dimensional spheroids as in vitro preclinical models for cancer research","volume":"12","author":"Pinto","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mcpro.2026.101610_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40580-022-00349-z","article-title":"Bolstering the secretion and bioactivities of umbilical cord MSC-derived extracellular vesicles with 3D culture and priming in chemically defined media","volume":"9","author":"Kim","year":"2022","journal-title":"Nano Converg."},{"key":"10.1016\/j.mcpro.2026.101610_bib36","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1073\/pnas.1220998110","article-title":"Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development","volume":"110","author":"Kucharzewska","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2026.101610_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12929-024-00997-9","article-title":"Modelling the complex nature of the tumor microenvironment: 3D tumor spheroids as an evolving tool","volume":"31","author":"Rodrigues","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.mcpro.2026.101610_bib38","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/ijms22031463","article-title":"CD44 and tumor-derived extracellular vesicles (TEVs). Possible gateway to cancer metastasis","volume":"22","author":"Szatanek","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcpro.2026.101610_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0315890","article-title":"Identification of distinct profiles of glioblastoma through the immunocapture of extracellular vesicles from patient plasma","volume":"20","author":"Manu","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.mcpro.2026.101610_bib40","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.prp.2016.07.002","article-title":"Immunohistochemical expression of stem cell markers CD44 and nestin in glioblastomas: evaluation of their prognostic significance","volume":"212","author":"Guadagno","year":"2016","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.mcpro.2026.101610_bib41","doi-asserted-by":"crossref","first-page":"19634","DOI":"10.18632\/oncotarget.3839","article-title":"CD44 enhances tumor aggressiveness by promoting tumor cell plasticity","volume":"6","author":"Paulis","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mcpro.2026.101610_bib42","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.18632\/oncotarget.3365","article-title":"Coexpression analysis of CD133 and CD44 identifies proneural and Mesenchymal subtypes of glioblastoma multiforme","volume":"6","author":"Brown","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mcpro.2026.101610_bib43","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/cam4.2714","article-title":"CD44-associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage","volume":"9","author":"Liu","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.mcpro.2026.101610_bib44","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3892\/ijo.2012.1530","article-title":"Periostin activates integrin \u03b15\u03b21 through a PI3K\/AKT-dependent pathway in invasion of cholangiocarcinoma","volume":"41","author":"UTISPAN","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.mcpro.2026.101610_bib45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1476-4598-11-66","article-title":"Integrin \u03b1v\u03b23 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2\/Smad 5\/receptor activator of NF-\u03baB ligand signaling axis","volume":"11","author":"Gupta","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mcpro.2026.101610_bib46","doi-asserted-by":"crossref","first-page":"13329","DOI":"10.2147\/OTT.S273803","article-title":"The roles of Integrin \u03b15\u03b21 in human cancer","volume":"13","author":"Hou","year":"2020","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.mcpro.2026.101610_bib47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/med.21408","article-title":"The Epithelial-to-Mesenchymal transition-like process in glioblastoma: an updated systematic review and in Silico investigation","volume":"37","author":"Iser","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.mcpro.2026.101610_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109184","article-title":"Proneural-mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in glioblastoma","volume":"27","author":"BV","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.mcpro.2026.101610_bib49","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1021\/acs.molpharmaceut.9b01271","article-title":"Combating glioblastoma by codelivering the small-molecule inhibitor of STAT3 and STAT3siRNA with \u03b15\u03b21 Integrin receptor-selective liposomes","volume":"17","author":"Vangala","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mcpro.2026.101610_bib50","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1074\/jbc.M611871200","article-title":"Phosphorylation of \u03b2-Catenin by AKT promotes \u03b2-Catenin transcriptional activity","volume":"282","author":"Fang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcpro.2026.101610_bib53","first-page":"16","article-title":"Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism","volume":"1632","author":"Hanada","year":"2003","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.mcpro.2026.101610_bib54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2014.07.009","article-title":"Focal adhesion signaling and therapy resistance in cancer","volume":"31","author":"Eke","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.mcpro.2026.101610_bib55","doi-asserted-by":"crossref","first-page":"9107","DOI":"10.3390\/ijms21239107","article-title":"The crosstalk between FAK and wnt signaling pathways in cancer and its therapeutic implication","volume":"21","author":"W\u00f6rthm\u00fcller","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcpro.2026.101610_bib56","doi-asserted-by":"crossref","first-page":"62194","DOI":"10.18632\/oncotarget.11552","article-title":"Expression\/activation of \u03b15\u03b21 integrin is linked to the \u03b2-catenin signaling pathway to drive migration in glioma cells","volume":"7","author":"Renner","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mcpro.2026.101610_bib57","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.molcel.2018.03.029","article-title":"SOD1 phosphorylation by mTORC1 couples nutrient sensing and redox regulation","volume":"70","author":"Tsang","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mcpro.2026.101610_bib58","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jhep.2013.02.030","article-title":"Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression","volume":"59","author":"Morita","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mcpro.2026.101610_bib59","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1568-7864(03)00116-2","article-title":"Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of topoisomerase I-mediated DNA lesions","volume":"2","author":"Plo","year":"2003","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.mcpro.2026.101610_bib60","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41467-022-29016-x","article-title":"The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma","volume":"13","author":"Chang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2026.101610_bib61","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/bies.950191104","article-title":"Zyxin: zinc fingers at sites of cell adhesion","volume":"19","author":"Beckerle","year":"1997","journal-title":"BioEssays"},{"key":"10.1016\/j.mcpro.2026.101610_bib62","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/15476286.2018.1440875","article-title":"Regulation of eukaryotic elongation factor 1 alpha (eEF1A) by dynamic lysine methylation","volume":"15","author":"Jakobsson","year":"2018","journal-title":"RNA Biol."},{"key":"10.1016\/j.mcpro.2026.101610_bib63","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4161\/auto.24229","article-title":"Repairing DNA damage by XRCC6\/KU70 reverses TLR4-deficiency-worsened HCC development via restoring senescence and autophagic flux","volume":"9","author":"Wang","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.mcpro.2026.101610_bib64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mrgentox.2018.05.018","article-title":"The role of p38 MAPK pathway in p53 compromised state and telomere mediated DNA damage response","volume":"836","author":"Roy","year":"2018","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.mcpro.2026.101610_bib65","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1038\/s12276-021-00700-0","article-title":"Oxidative damage-induced hyperactive ribosome biogenesis participates in tumorigenesis of offspring by cross-interacting with the Wnt and TGF-\u03b21 pathways in IVF embryos","volume":"53","author":"Huang","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.mcpro.2026.101610_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jare.2025.02.002","article-title":"PA2G4 in health and disease: an underestimated multifunctional regulator","author":"Jia","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.mcpro.2026.101610_bib67","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41589-024-01760-9","article-title":"Delineating cysteine-reactive compound modulation of cellular proteostasis processes","volume":"21","author":"Julio","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.mcpro.2026.101610_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2008.11.003","article-title":"Histone H1 and its isoforms: contribution to chromatin structure and function","volume":"431","author":"Happel","year":"2009","journal-title":"Gene"},{"key":"10.1016\/j.mcpro.2026.101610_bib69","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41577-024-01098-2","article-title":"The roles of arginases and arginine in immunity","volume":"25","author":"Can\u00e8","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mcpro.2026.101610_bib70","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142137","article-title":"Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors","volume":"132","author":"Hajji","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mcpro.2026.101610_bib71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12974-020-01797-2","article-title":"Glioblastoma hijacks microglial gene expression to support tumor growth","volume":"17","author":"Maas","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.mcpro.2026.101610_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aar2766","article-title":"Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles","volume":"4","author":"Ricklefs","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mcpro.2026.101610_bib73","doi-asserted-by":"crossref","DOI":"10.20517\/cdr.2020.79","article-title":"Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review","author":"Singh","year":"2020","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.mcpro.2026.101610_bib74","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1007\/s12035-024-04041-7","article-title":"Downregulating DNA methyltransferase 3B by suppressing the PI3K\/Akt signaling pathway enhances the chemosensitivity of glioblastoma to temozolomide","volume":"61","author":"Kan","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mcpro.2026.101610_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229534","article-title":"Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions","volume":"15","author":"Belter","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.mcpro.2026.101610_bib76","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.2174\/0929867326666181203133332","article-title":"Targeting the ribosome biogenesis key molecule fibrillarin to avoid chemoresistance","volume":"26","author":"El","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.mcpro.2026.101610_bib77","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/s41417-022-00470-5","article-title":"SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells","volume":"29","author":"Zhang","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.mcpro.2026.101610_bib78","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1261\/rna.036665.112","article-title":"The T. brucei TRM5 methyltransferase plays an essential role in mitochondrial protein synthesis and function","volume":"19","author":"Paris","year":"2013","journal-title":"RNA"},{"key":"10.1016\/j.mcpro.2026.101610_bib79","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s10637-021-01144-z","article-title":"Serine hydroxymethyltransferase 2: a novel target for human cancer therapy","volume":"39","author":"Xie","year":"2021","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.mcpro.2026.101610_bib80","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1158\/2159-8290.CD-14-0250","article-title":"Serine catabolism regulates mitochondrial redox control during hypoxia","volume":"4","author":"Ye","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.mcpro.2026.101610_bib81","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJMoa2314390","article-title":"Intraventricular CARv3-TEAM-E T cells in recurrent glioblastoma","volume":"390","author":"Choi","year":"2024","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.mcpro.2026.101610_bib82","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3390\/ijms21051588","article-title":"Replication Protein A (RPA) mediates radio-resistance of glioblastoma cancer stem-like cells","volume":"21","author":"Pedersen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcpro.2026.101610_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/2793222","article-title":"Highly expressed CYBRD1 associated with glioma recurrence regulates the immune response of glioma cells to Interferon","volume":"2021","author":"Qing","year":"2021","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.mcpro.2026.101610_bib84","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41589-022-01219-9","article-title":"Structure, sequon recognition and mechanism of tryptophan C-mannosyltransferase","volume":"19","author":"Bloch","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.mcpro.2026.101610_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.650534","article-title":"High level of METTL7B indicates poor prognosis of patients and is related to immunity in Glioma","volume":"11","author":"Xiong","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.mcpro.2026.101610_bib86","doi-asserted-by":"crossref","first-page":"18297","DOI":"10.18632\/aging.103695","article-title":"Glioblastoma cell differentiation trajectory predicts the immunotherapy response and overall survival of patients","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.mcpro.2026.101610_bib87","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.3390\/cancers16223748","article-title":"Exploring extracellular vesicle surface protein markers produced by glioblastoma tumors: a characterization Study using in vitro 3D patient-derived cultures","volume":"16","author":"Franceschi","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mcpro.2026.101610_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107377","article-title":"CK2\u2013HTATSF1\u2013TOPBP1 signaling axis modulates tumor chemotherapy response","volume":"300","author":"Guo","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcpro.2026.101610_bib89","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1093\/nar\/gkac817","article-title":"Human NOP2\/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C\/D snoRNPs","volume":"50","author":"Liao","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcpro.2026.101610_bib90","article-title":"Molecular characterization clinical and immunotherapeutic characteristics of m5C regulator NOP2 across 33 cancer types","volume":"10","author":"Liu","year":"2022","journal-title":"Front Cell Dev. Biol."}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947626001064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947626001064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:04:49Z","timestamp":1785326689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947626001064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":88,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1535947626001064"],"URL":"https:\/\/doi.org\/10.1016\/j.mcpro.2026.101610","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular Vesicles From Glioblastoma Cells Reflect 2D vs. 3D Culture Adaptation and Resistance to Temozolomide","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcpro.2026.101610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"101610"}}